Whole-genome sequencing to control antimicrobial resistance

Claudio U. Köser*, Matthew Ellington, Sharon Peacock

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

160 Citations (Scopus)


Following recent improvements in sequencing technologies, whole-genome sequencing (WGS) is positioned to become an essential tool in the control of antibiotic resistance, a major threat in modern healthcare. WGS has already found numerous applications in this area, ranging from the development of novel antibiotics and diagnostic tests through to antibiotic stewardship of currently available drugs via surveillance and the elucidation of the factors that allow the emergence and persistence of resistance. Numerous proof-of-principle studies have also highlighted the value of WGS as a tool for day-to-day infection control and, for some pathogens, as a primary diagnostic tool to detect antibiotic resistance. However, appropriate data analysis platforms will need to be developed before routine WGS can be introduced on a large scale.

Original languageEnglish
Pages (from-to)401-407
Number of pages7
JournalTrends in Genetics
Issue number9
Publication statusPublished - Sep 2014


  • Antibiotic resistance
  • Diagnostics
  • Surveillance
  • Whole-genome sequencing


Dive into the research topics of 'Whole-genome sequencing to control antimicrobial resistance'. Together they form a unique fingerprint.

Cite this